For 12+ years, the team of Carl McEvoy and Michael Farmer have conducted exhaustive on-the-ground research in Asia, and most notabably China, interviewing lab employees and executives to obtain an accurate picture of the IVD market in China and other countries. In cooperation with Kalorama Information this report Molecular Diagnostics in China, is the definitive measure of PCR testing in China. A high volume of PCR testing is peformed in China, with thousands of hospital labs performing tests. From 2000 to 2004, the PCR market in China nearly doubled. Growth rate has moderated substantially to 10-15% in the last couple of years.

Those watching the Chinese IVD markets will find this to be a critical resource with the following information:

A Review of Developments in Chinese IVD
Markets for Molecular Diagnostics in China
Instrument and Reagent Segments
Government Activity Related to PCR Testing
Market Share of Major Players
Company Profiles

Information in the report is taken from Kalorama Inforamtion's edition of McEvoy and Farmer's Clinical Diagnostics in China, Market Summary and Participant Directory.

Customers seeking market information for the entire Chinese IVD Market across categories should purchase that publication.

Chapter One: Executive Summary
- What's New in China
- Molecular Diagnostics in China
- Company Profiles
- A Note on Names and Spelling
- Abbreviations Used in This Report
Chapter Two: Country Summary
- What's New in China
- The Healthcare System in China
- Privatization
- Private and Reference Laboratories
- Private Medical Practice
- Medical Insurance
- A Brief Guide to the Bureaucracy
- Product Registration
- The "Clean" Campaign
- Reimbursement
- Tenders
- Reagent Rental
- Quality Control
- Vacuum Tube Conversion
- Consolidated Work Stations and Sample Automation
- Second-hand Instruments
Chapter Three: Market Analysis
- Commentary
- Market Leaders
- Pricing and Reimbursement
- Quality Issues
- Other Molecular Products
- International Companies
Chapter Four: Company Profiles
- Abbott Laboratories
- Applied Biosystems
- Amplly
- Bioer Technology
- Bio-Hema
- BioMrieux (France)
- Bayer HealthCare (US)
- Da An Gene
- Elikan Biological Technology
- Fosun Diagnostics
- Gene Company
- Haoyuan Biotechnology
- HealthDigit
- Intec Products
- Kehua Biotech
- Lengguang Technology
- Promega (US)
- PG (PiGi)
- Qiagen
- Roche
- Sciarray Biotech
- Science International/Science Laboratories
- Sino-American Biotechnology Company
- TABLE OF EXHIBITS
Chapter One: Executive Summary
- Exhibit 1: Chinese IVD Market, 1996-2006
- Exhibit 2: Chinese Molecular Diagnostics Market, 2006
Chapter Two: Country Summary
- Exhibit 3: Hospitals in China by Level (Level I, II, III, A, B, C and Unrated)
- Exhibit 4 Hospitals in China by Number of Beds
Chapter Three: Market Analysis
- Exhibit 6: Reagent Sales in China (Infectious Disease, Other)
- Exhibit 7: Instrument Sales in China (Units Placed, Units Rented, Units Sold,
- Average Price)
- Exhibit 8: Molecular Diagnostics in China
- Exhibit 9: Reagent Market in China by Category
- (Kinetic/QPCR, Traditional, Other)
- Exhibit 10: Instruments in China by Category (End Point, Kinetic)
- Exhibit 11: Market Leaders
- Exhibit 12: Average Price Lists for PCR Tests
- Exhibit 13: Key Analytes (Analyte, Market Share)
- Exhibit 14: Reimbursement Range for Kinetic Molecular Testing
- Exhibit 15: Molecular Testing Distribution Companies

Pharmaceutical Market Research

Molecular Diagnostics in China

Molecular Diagnostics in China

Contents

Related products